- Home
- LZB vs NVCR Comparison
LZB vs NVCR Comparison
Compare LZB & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LZB
- NVCR
- Stock Information
- Founded
- LZB 1927
- NVCR 2000
- Country
- LZB United States
- NVCR Switzerland
- Employees
- LZB N/A
- NVCR N/A
- Industry
- LZB Home Furnishings
- NVCR Medical/Dental Instruments
- Sector
- LZB Consumer Discretionary
- NVCR Health Care
- Exchange
- LZB Nasdaq
- NVCR Nasdaq
- Market Cap
- LZB 1.6B
- NVCR 1.9B
- IPO Year
- LZB N/A
- NVCR 2015
- Fundamental
- Price
- LZB $39.35
- NVCR $17.60
- Analyst Decision
- LZB Buy
- NVCR Buy
- Analyst Count
- LZB 2
- NVCR 7
- Target Price
- LZB $46.00
- NVCR $32.43
- AVG Volume (30 Days)
- LZB 589.0K
- NVCR 1.4M
- Earning Date
- LZB 08-19-2025
- NVCR 07-24-2025
- Dividend Yield
- LZB 2.20%
- NVCR N/A
- EPS Growth
- LZB N/A
- NVCR N/A
- EPS
- LZB 2.35
- NVCR N/A
- Revenue
- LZB $2,109,207,000.00
- NVCR $621,711,000.00
- Revenue This Year
- LZB $3.83
- NVCR $5.56
- Revenue Next Year
- LZB $3.88
- NVCR $9.19
- P/E Ratio
- LZB $17.03
- NVCR N/A
- Revenue Growth
- LZB 3.04
- NVCR 18.27
- 52 Week Low
- LZB $35.18
- NVCR $14.17
- 52 Week High
- LZB $48.31
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- LZB 49.67
- NVCR 49.74
- Support Level
- LZB $38.61
- NVCR $16.81
- Resistance Level
- LZB $41.06
- NVCR $18.59
- Average True Range (ATR)
- LZB 1.07
- NVCR 0.74
- MACD
- LZB 0.27
- NVCR 0.08
- Stochastic Oscillator
- LZB 59.29
- NVCR 56.18
About LZB La-Z-Boy Incorporated
La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.